about
RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolismAssociation of the human SUMO-1 protease SENP2 with the nuclear poreSumoylation delays the ATF7 transcription factor subcellular localization and inhibits its transcriptional activityParkin ubiquitinates and promotes the degradation of RanBP2Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivoThe SUMO E3 ligase activity of Pc2 is coordinated through a SUMO interaction motifSumoylated SnoN represses transcription in a promoter-specific mannerEnzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex.Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formationProteomic analysis of the mammalian nuclear pore complexAn extended consensus motif enhances the specificity of substrate modification by SUMOThe nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processingStructure of Importin13-Ubc9 complex: nuclear import and release of a key regulator of sumoylationUbc9 acetylation modulates distinct SUMO target modification and hypoxia responseRhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicitySUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycleMAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fissionIn silico structural and functional characterization of the RSUME splice variantsRegulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications.Sumoylation of the zinc finger protein ZXDC enhances the function of its transcriptional activation domainSUMOylation and SUMO-interacting motif (SIM) of metastasis tumor antigen 1 (MTA1) synergistically regulate its transcriptional repressor functionAssociation with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.Human MMS21/NSE2 is a SUMO ligase required for DNA repairModification with SUMO. A role in transcriptional regulationTranscription factor Sp3 is silenced through SUMO modification by PIAS1The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylaseRole for SUMO modification in facilitating transcriptional repression by BKLF.The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like proteinSENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expressionImportin α/β mediates nuclear import of individual SUMO E1 subunits and of the holo-enzymeThe nuclear envelopehZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication fociStructure of the Siz/PIAS SUMO E3 ligase Siz1 and determinants required for SUMO modification of PCNAResolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalphaHistone sumoylation is associated with transcriptional repressionNup358 integrates nuclear envelope breakdown with kinetochore assemblySumoylation is involved in beta-catenin-dependent activation of Tcf-4Role of desumoylation in the development of prostate cancer
P2860
Q21145250-D2FB1BA6-CA48-4166-9AD8-3206CB89FDA4Q24292472-F589366E-7904-459A-9C12-2CB6B8180BD3Q24294867-097D3DAE-EABA-4A29-BB19-F0C1DDCEB8BCQ24298223-093405D2-FC51-40A8-B433-9DE3D8ACB600Q24299957-ECC82BAC-C6E2-4AE4-8E66-7253156E3930Q24300562-769A1116-B930-4BF2-AA6D-88A59AF3084FQ24302417-CB45055D-F0E0-4E2A-8BAD-0C364C70B3EDQ24305181-676BEFC6-CC6F-4066-9F60-FAFB80C35B2BQ24305202-59BFBA56-15C1-4C4E-B5F1-BFAB3CFD45A4Q24305242-8C16DA99-633B-4D6C-9A22-CA712011EFB7Q24306729-58F57F3C-A175-488F-B013-79D14D9BEDABQ24312057-E715E50E-256F-471D-8769-F33F2EBE8F5AQ24313610-67B0E9CC-6532-4111-AD4B-EE6F842E5807Q24315889-0A74CFAA-8062-4D0D-B01E-974D240AFB19Q24317318-F7D1460C-3927-4211-B467-EC41E58BD1E3Q24318317-9D48ADCB-313A-4EC3-97C7-5EF5BF5BE659Q24320331-0385905B-9531-4DD7-956D-DCCDBE203F6BQ24323152-3C0045E0-F86D-464D-86D6-3C235CA4EE5FQ24324035-0CA851F3-DAC1-421F-B319-183C1E202632Q24337359-C7FBAD92-A061-4E8B-86AC-1A4D7BC498D8Q24339302-8EC30DAD-0EC6-44DA-A21B-7439A88154A8Q24519076-8A70724B-F117-4B3F-A301-67C059CBC93FQ24529880-63E2768F-FEFC-44C6-BA95-73B88CC4B1F5Q24529887-D02591F3-C260-4142-8280-E7D90E4DF9E4Q24534589-013AA60C-C950-4D87-9EBC-D6DCE29532F5Q24534887-F147C85B-6B9C-416D-98DE-8F3E3CAA1224Q24534918-25B9AD29-F791-4ED9-A5C2-5AB3D399D67AQ24556900-BDA8AD21-E2DA-4D8B-A9EA-B60178D39EDEQ24562149-198A0B07-1601-4C13-8FCE-EC83D5BD74D1Q24563640-8CF1EDEB-8968-43DA-AF7A-C9010530DA8CQ24604578-D84C06E4-137F-4711-A44A-3BDD70243DBDQ24613093-A6E7FFCD-6AE3-429C-AE5B-92688C62DD99Q24634678-1309ADF2-5C35-4FE7-8860-3EEA0B1ED7F6Q24644349-4D0D0E5D-950C-4554-A5B8-2D37411A04FAQ24645940-B5834326-373A-44E5-AE2E-C54EC8989349Q24648999-3C44664D-A873-4A7C-AE07-0490D8964749Q24656259-8C606C6A-0832-4753-9B2B-BA0F12D61DD3Q24675421-7B6A1137-9ADA-4520-BF11-7858211D27B1Q24675969-9B93141E-8C13-4172-BA9C-919990249508Q24676101-6CF49FA8-3C4B-498B-879D-3872C07C7E15
P2860
description
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Januar 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/01/11)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/01/11)
@nl
наукова стаття, опублікована в січні 2002
@uk
مقالة علمية (نشرت في 11-1-2002)
@ar
name
The nucleoporin RanBP2 has SUMO1 E3 ligase activity
@ast
The nucleoporin RanBP2 has SUMO1 E3 ligase activity
@en
The nucleoporin RanBP2 has SUMO1 E3 ligase activity
@nl
type
label
The nucleoporin RanBP2 has SUMO1 E3 ligase activity
@ast
The nucleoporin RanBP2 has SUMO1 E3 ligase activity
@en
The nucleoporin RanBP2 has SUMO1 E3 ligase activity
@nl
prefLabel
The nucleoporin RanBP2 has SUMO1 E3 ligase activity
@ast
The nucleoporin RanBP2 has SUMO1 E3 ligase activity
@en
The nucleoporin RanBP2 has SUMO1 E3 ligase activity
@nl
P2093
P3181
P1433
P1476
The nucleoporin RanBP2 has SUMO1 E3 ligase activity
@en
P2093
Andrea Pichler
Andreas Gast
Anne Dejean
P304
P3181
P356
10.1016/S0092-8674(01)00633-X
P407
P577
2002-01-01T00:00:00Z